Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership

By LabMedica International staff writers
Posted on 10 May 2024

Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. More...

Beckman Coulter is now an authorized distributor of the MeMed BV assay, a rapid immunoassay test that can differentiate between bacterial and viral infections, and MeMed Key, a compact immunoassay analyzer which is cleared to run the MeMed BV assay in the United States and Europe. The latest distribution agreement complements the existing joint effort by both companies to develop a MeMed BV-based test for Beckman Coulter's family of Access Immunoassay Analyzers.

Differentiating between bacterial and viral infections can often be challenging for physicians due to similar presenting symptoms, leading to potential misuse of antibiotics. The MeMed BV test, employing a machine learning algorithm, combines measurements of three critical immune response proteins (TRAIL, IP-10, and CRP) to indicate the likelihood of bacterial versus viral infections. This test’s efficacy has been confirmed through extensive validation studies internationally and is now gaining traction in clinical settings across the U.S. and Europe, with over 20,000 patients tested.

Recent studies have indicated that in about 29% of cases, clinicians encounter difficulties in distinguishing between bacterial and viral infections, which can delay effective decision-making and disrupt diagnostic processes. The MeMed BV assay has been shown to influence or change physician decisions in 87% of cases, demonstrating its significant impact on clinical practices (p < 0.05). The test delivers results within 15 minutes using serum or whole blood and has a greater than 99% negative predictive value for excluding bacterial infections.

"Beckman Coulter's commitment to improving infection management is unwavering," said Kevin O'Reilly, President, Beckman Coulter. "To that end, we are excited to extend our partnership with MeMed by expanding market access to the MeMed Key and BV assay. These MeMed innovations complement Beckman Coulter's portfolio of host response diagnostics, including our CBC-based hematological biomarker MDW [monocyte distribution width] identifying the presence of severe infection and risk of sepsis, our clinical chemistry PCT [procalcitonin] assay aiding risk assessment for septic shock, and our full suite of microbiology solutions providing faster time to optimize antibiotic therapies."

"We're excited to expand our partnership with Beckman Coulter, taking an additional step forward in our shared mission to advance pioneering host-response solutions,” added Dr. Eran Eden, MeMed's CEO and co-founder. “This expansion focuses on two main objectives: first, to educate and prime the market to accelerate the adoption of MeMed BV once it's cleared for use on Beckman Coulter's core-lab immunoassay analyzers; second, to broaden patient access to MeMed BV through a strategic hub and spoke model. By combining the capabilities of Beckman Coulter's analyzers with the MeMed Key's ability to deliver results directly from whole blood within minutes, we're creating a synergistic ecosystem that aids clinicians in distinguishing between bacterial and viral infections with unprecedented ease and precision."


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.